vs

Side-by-side financial comparison of AvalonBay Communities (AVB) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $767.9M, roughly 1.6× AvalonBay Communities). AvalonBay Communities runs the higher net margin — 9040.6% vs 21.2%, a 9019.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.8%).

AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

AVB vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.6× larger
DXCM
$1.3B
$767.9M
AVB
Growing faster (revenue YoY)
DXCM
DXCM
+17.9% gap
DXCM
21.6%
3.7%
AVB
Higher net margin
AVB
AVB
9019.4% more per $
AVB
9040.6%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
3.8%
AVB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AVB
AVB
DXCM
DXCM
Revenue
$767.9M
$1.3B
Net Profit
$166.0M
$267.3M
Gross Margin
62.9%
Operating Margin
64.2%
25.6%
Net Margin
9040.6%
21.2%
Revenue YoY
3.7%
21.6%
Net Profit YoY
-41.2%
153.6%
EPS (diluted)
$1.18
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVB
AVB
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$767.9M
$1.3B
Q3 25
$766.8M
$1.2B
Q2 25
$760.2M
$1.2B
Q1 25
$745.9M
$1.0B
Q4 24
$740.5M
$1.1B
Q3 24
$734.3M
$994.2M
Q2 24
$726.0M
$1.0B
Net Profit
AVB
AVB
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$166.0M
$267.3M
Q3 25
$381.3M
$283.8M
Q2 25
$268.7M
$179.8M
Q1 25
$236.6M
$105.4M
Q4 24
$282.1M
$151.7M
Q3 24
$372.5M
$134.6M
Q2 24
$253.9M
$143.5M
Gross Margin
AVB
AVB
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
AVB
AVB
DXCM
DXCM
Q1 26
25.6%
Q4 25
64.2%
25.6%
Q3 25
65.7%
20.1%
Q2 25
67.6%
18.4%
Q1 25
68.5%
12.9%
Q4 24
63.1%
17.0%
Q3 24
65.4%
15.3%
Q2 24
66.6%
15.7%
Net Margin
AVB
AVB
DXCM
DXCM
Q1 26
21.2%
Q4 25
9040.6%
21.2%
Q3 25
49.7%
23.5%
Q2 25
35.3%
15.5%
Q1 25
31.7%
10.2%
Q4 24
38.1%
13.6%
Q3 24
50.7%
13.5%
Q2 24
35.0%
14.3%
EPS (diluted)
AVB
AVB
DXCM
DXCM
Q1 26
$0.67
Q4 25
$1.18
$0.67
Q3 25
$2.68
$0.70
Q2 25
$1.88
$0.45
Q1 25
$1.66
$0.27
Q4 24
$1.99
$0.37
Q3 24
$2.61
$0.34
Q2 24
$1.78
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVB
AVB
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$187.2M
$917.7M
Total DebtLower is stronger
$9.3B
Stockholders' EquityBook value
$11.6B
$2.7B
Total Assets
$22.2B
$6.3B
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVB
AVB
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$187.2M
$917.7M
Q3 25
$123.3M
$1.8B
Q2 25
$102.8M
$1.2B
Q1 25
$53.3M
$904.9M
Q4 24
$108.6M
$606.1M
Q3 24
$552.4M
$621.2M
Q2 24
$545.8M
$939.2M
Total Debt
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
$9.3B
Q3 25
$8.7B
Q2 25
$8.7B
Q1 25
$8.3B
Q4 24
$8.1B
Q3 24
$8.4B
Q2 24
$8.4B
Stockholders' Equity
AVB
AVB
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$11.6B
$2.7B
Q3 25
$11.9B
$2.7B
Q2 25
$11.9B
$2.6B
Q1 25
$11.9B
$2.3B
Q4 24
$11.9B
$2.1B
Q3 24
$11.9B
$2.0B
Q2 24
$11.7B
$2.4B
Total Assets
AVB
AVB
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$22.2B
$6.3B
Q3 25
$21.9B
$7.5B
Q2 25
$21.8B
$7.3B
Q1 25
$21.2B
$6.8B
Q4 24
$21.0B
$6.5B
Q3 24
$21.3B
$6.4B
Q2 24
$21.0B
$6.8B
Debt / Equity
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
0.80×
Q3 25
0.73×
Q2 25
0.72×
Q1 25
0.70×
Q4 24
0.68×
Q3 24
0.70×
Q2 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVB
AVB
DXCM
DXCM
Operating Cash FlowLast quarter
$1.7B
Free Cash FlowOCF − Capex
$1.4B
FCF MarginFCF / Revenue
183.5%
Capex IntensityCapex / Revenue
34.1%
Cash ConversionOCF / Net Profit
10.07×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
$1.7B
$294.0M
Q3 25
$477.0M
$659.9M
Q2 25
$377.8M
$303.0M
Q1 25
$415.9M
$183.8M
Q4 24
$1.6B
$301.4M
Q3 24
$486.2M
$199.5M
Q2 24
$380.0M
$279.4M
Free Cash Flow
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
$1.4B
$192.1M
Q3 25
$402.2M
$579.4M
Q2 25
$317.1M
$208.9M
Q1 25
$367.5M
$96.8M
Q4 24
$1.4B
$176.8M
Q3 24
$434.2M
$88.3M
Q2 24
$333.0M
$213.3M
FCF Margin
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
183.5%
15.3%
Q3 25
52.5%
47.9%
Q2 25
41.7%
18.1%
Q1 25
49.3%
9.3%
Q4 24
191.0%
15.9%
Q3 24
59.1%
8.9%
Q2 24
45.9%
21.2%
Capex Intensity
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
34.1%
8.1%
Q3 25
9.8%
6.7%
Q2 25
8.0%
8.1%
Q1 25
6.5%
8.4%
Q4 24
26.1%
11.2%
Q3 24
7.1%
11.2%
Q2 24
6.5%
6.6%
Cash Conversion
AVB
AVB
DXCM
DXCM
Q1 26
Q4 25
10.07×
1.10×
Q3 25
1.25×
2.33×
Q2 25
1.41×
1.69×
Q1 25
1.76×
1.74×
Q4 24
5.70×
1.99×
Q3 24
1.31×
1.48×
Q2 24
1.50×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons